INOV Inovalon Holdings Inc. Class A

Humana Expands Use of the Inovalon ONE® Platform

Humana Expands Use of the Inovalon ONE® Platform

Leading National Health Plan to Implement Vaccine Adherence Program

BOWIE, Md., March 22, 2021 (GLOBE NEWSWIRE) --  (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, and Humana (NYSE: HUM), a leading national consumer-focused, technology-driven health plan known for its commitment to innovation, today announced the expansion of their collaboration in a focus on vaccine adherence.

Under the engagement, Inovalon will implement the Inovalon ONE® Platform Vaccine Adherence Program, leveraging established healthcare ecosystem connectivity, data integration, normalization, and analyses to assess clinical applicability and adherence of health plan members to applicable Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) immunization schedules and guidelines. Analytical insights delivered through the data-driven program will inform member engagement and disease education efforts to promote uptake of recommended vaccines, resulting in improved health outcomes, quality ratings and overall public health, as well as significant economic benefits stemming from reductions in vaccine-preventable disease incidence and associated treatment costs. 

The broader Inovalon and Humana engagement dates back to early 2019 with the implementation of a configuration of the Inovalon ONE® Platform focused on achieving advanced insight into member conditions and the subsequent empowering of data-driven initiatives to benefit Humana’s Commercial membership. A leading specialty pharmacy operator, Humana expanded the relationship later in 2019 to include Inovalon’s ScriptMed® Cloud offering, a configuration of the Inovalon ONE® Platform designed to combine superior analytically driven care protocols with superior quality, operational processes, and cost efficiencies for pharmacies. In early 2020, Humana added Inovalon’s Virtual Health Visit capabilities and later in 2020 expanded the application of the Inovalon ONE® Platform to Humana’s Medicare membership.

“We are very pleased and appreciative to expand our relationship with such an industry innovator as Humana,” said Keith Dunleavy, M.D., chief executive officer of Inovalon. “Humana’s commitment to their members’ quality of care as well as their commitment to partnership in progressing programs together has been remarkable.”

About Inovalon

Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including all 25 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 574,000 clinical facilities, 332 million Americans, and 61 billion medical events. For more information, visit .

Contact:

Kim E. Collins

Senior Vice President, Corporate Communications



301-809-4000 x1473

Hulus Alpay

Vice President, Investor Relations



301-809-4000 x1237



EN
22/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inovalon Holdings Inc. Class A

 PRESS RELEASE

Equity Consortium Led by Nordic Capital and Including Insight Partners...

Equity Consortium Led by Nordic Capital and Including Insight Partners Completes Acquisition of Inovalon Partnership to Advance Inovalon’s Mission of Empowering Data-Driven Healthcare BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders o...

 PRESS RELEASE

Pharmacy Leaders and Technology Innovators Convene Virtually November ...

Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021 Industry Experts Highlight Strategies for Advancing Data Sharing and Improving Pharmaceutical Patient Care at Inovalon’s ScriptMed® Conference BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry’s leading executives and thought leaders discussing the ways in which techno...

 PRESS RELEASE

Inovalon to Host Virtual Client Congress October 18-19, 2021

Inovalon to Host Virtual Client Congress October 18-19, 2021 Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation’s most influential voices to address the programs, perspectives, an...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2021 08 31

CTSH has built an industry-leading asset-based consulting business over the past 15 years, seeing remarkably stable returns and steady investment in growth, through various economic cycles and potentially impactful regulatory changes. However, the market is expecting both their ability to drive growth and sustain and improve profitability to severely erode going forward, with UAFRS-based (Uniform) ROA falling by half and growth slowing too. While markets are overly pessimistic, management is al...

Valens Research
  • Valens Research

INOV - Embedded Expectations Analysis - 2021 08 30

Inovalon Holdings, Inc. (INOV:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 37.0x Uniform P/E, implying somewhat bullish expectations for the firm. However, although management's concerns about revenue guidance, contract wins, and sales trend disruptions suggest potential short-term headwinds, market expectations are still too pessimistic, and longer-term equity outperformance remains warranted. Specifically, management may lack confidence in ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch